Luc Meva’a Mbaze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luc Meva’a Mbaze has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Fidele Ntie-Kang
University of Buea
15 shared publications - Wolfgang Sippl
Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany
12 shared publications - Lydia Likowo Lifongo
Chemical and Bioactivity Information Centre, Department of Chemistry, Faculty of Science, University of Buea, PO Box 63, Buea, Cameroon
7 shared publications - Conrad Veranso Simoben
Structural Genomics Consortium University of Toronto Toronto Ontario Canada
6 shared publications - Pascal Amoa Onguéné
Department of Chemistry, Faculty of Science, University of Douala, P. O. Box 24157, Douala, Cameroon
5 shared publications - Eugene Megnassan
Laboratoire de Physique Fondamentale et Appliquée (LPFA), University of Abobo Adjamé (Now Nangui Abrogoua), Abidjan 02, Côte d’Ivoire
4 shared publications
Latest Publications
- 1 February 2018
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 72, 136-149
In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties
- 1 February 2018
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 72, 136-149
In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties
- Open Access
- 1 July 2016
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 10, 2137-2154
Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants
Molecular modeling has been employed in the search for lead compounds of chemotherapy to fight cancer. In this study, pharmacophore models have been generated and validated for use in virtual screening protocols for eight known anticancer drug targets, including tyrosine kinase, protein kinase B β, cyclin-dependent kinase, protein farnesyltransferase, human protein kinase, glycogen synthase kinase, and indoleamine 2,3-dioxygenase 1. Pharmacophore models were validated through receiver operating characteristic and Güner–Henry scoring methods, indicating that several of the models generated could be useful for the identification of potential anticancer agents from natural product databases. The validated pharmacophore models were used as three-dimensional search queries for virtual screening of the newly developed AfroCancer database (~400 compounds from African medicinal plants), along with the Naturally Occurring Plant-based Anticancer Compound-Activity-Target dataset (comprising ~1,500 published naturally occurring plant-based compounds from around the world). Additionally, an in silico assessment of toxicity of the two datasets was carried out by the use of 88 toxicity end points predicted by the Lhasa’s expert knowledge-based system (Derek), showing that only an insignificant proportion of the promising anticancer agents would be likely showing high toxicity profiles. A diversity study of the two datasets, carried out using the analysis of principal components from the most important physicochemical properties often used to access drug-likeness of compound datasets, showed that the two datasets do not occupy the same chemical space.
- 1 July 2016
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 10, 2137-2154
Open AccessPharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants
Molecular modeling has been employed in the search for lead compounds of chemotherapy to fight cancer. In this study, pharmacophore models have been generated and validated for use in virtual screening protocols for eight known anticancer drug targets, including tyrosine kinase, protein kinase B β, cyclin-dependent kinase, protein farnesyltransferase, human protein kinase, glycogen synthase kinase, and indoleamine 2,3-dioxygenase 1. Pharmacophore models were validated through receiver operating characteristic and Güner–Henry scoring methods, indicating that several of the models generated could be useful for the identification of potential anticancer agents from natural product databases. The validated pharmacophore models were used as three-dimensional search queries for virtual screening of the newly developed AfroCancer database (~400 compounds from African medicinal plants), along with the Naturally Occurring Plant-based Anticancer Compound-Activity-Target dataset (comprising ~1,500 published naturally occurring plant-based compounds from around the world). Additionally, an in silico assessment of toxicity of the two datasets was carried out by the use of 88 toxicity end points predicted by the Lhasa’s expert knowledge-based system (Derek), showing that only an insignificant proportion of the promising anticancer agents would be likely showing high toxicity profiles. A diversity study of the two datasets, carried out using the analysis of principal components from the most important physicochemical properties often used to access drug-likeness of compound datasets, showed that the two datasets do not occupy the same chemical space.
- Open Access
- 5 September 2014
- Published by Springer Nature in Organic and Medicinal Chemistry Letters
- Vol. 4 (1) , 1-9
The potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling
Background: Malaria is an endemic disease affecting many countries in Tropical regions. In the search for compound hits for the design and/or development of new drugs against the disease, many research teams have resorted to African medicinal plants in order to identify lead compounds. Three-dimensional molecular models were generated for anti-malarial compounds of African origin (from 'weakly' active to 'highly' active), which were identified from literature sources. Selected computed molecular descriptors related to absorption, distribution, metabolism, excretion and toxicity (ADMET) of the phytochemicals have been analysed and compared with those of known drugs in order to access the 'drug-likeness' of these compounds. Results: In the present study, more than 500 anti-malarial compounds identified from 131 distinct medicinal plant species belonging to 44 plant families from the African flora have been considered. On the basis of Lipinski's 'Rule of Five', about 70% of the compounds were predicted to be orally bioavailable, while on the basis of Jorgensen's 'Rule of Three', a corresponding >80% were compliant. An overall drug-likeness parameter indicated that approximately 55% of the compounds could be potential leads for the development of drugs. Conclusions: From the above analyses, it could be estimated that >50% of the compounds exhibiting anti-plasmodial/anti-malarial activities, derived from the African flora, could be starting points for drug discovery against malaria. The 3D models of the compounds have been included as an accompanying file and could be employed in virtual screening.
- 5 September 2014
- Published by Springer Nature in Organic and Medicinal Chemistry Letters
- Vol. 4 (1) , 1-9
Open AccessThe potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling
Background: Malaria is an endemic disease affecting many countries in Tropical regions. In the search for compound hits for the design and/or development of new drugs against the disease, many research teams have resorted to African medicinal plants in order to identify lead compounds. Three-dimensional molecular models were generated for anti-malarial compounds of African origin (from 'weakly' active to 'highly' active), which were identified from literature sources. Selected computed molecular descriptors related to absorption, distribution, metabolism, excretion and toxicity (ADMET) of the phytochemicals have been analysed and compared with those of known drugs in order to access the 'drug-likeness' of these compounds. Results: In the present study, more than 500 anti-malarial compounds identified from 131 distinct medicinal plant species belonging to 44 plant families from the African flora have been considered. On the basis of Lipinski's 'Rule of Five', about 70% of the compounds were predicted to be orally bioavailable, while on the basis of Jorgensen's 'Rule of Three', a corresponding >80% were compliant. An overall drug-likeness parameter indicated that approximately 55% of the compounds could be potential leads for the development of drugs. Conclusions: From the above analyses, it could be estimated that >50% of the compounds exhibiting anti-plasmodial/anti-malarial activities, derived from the African flora, could be starting points for drug discovery against malaria. The 3D models of the compounds have been included as an accompanying file and could be employed in virtual screening.
- 25 August 2014
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 54 (9) , 2433-2450
Molecular Modeling of Potential Anticancer Agents from African Medicinal Plants
Naturally occurring anticancer compounds represent about half of the chemotherapeutic drugs which have been put in the market against cancer until date. Computer-based or in silico virtual screening methods are often used in lead/hit discovery protocols. In this study, the “drug-likeness” of ∼400 compounds from African medicinal plants that have shown in vitro and/or in vivo anticancer, cytotoxic, and antiproliferative activities has been explored. To verify potential binding to anticancer drug targets, the interactions between the compounds and 14 selected targets have been analyzed by in silico modeling. Docking and binding affinity calculations were carried out, in comparison with known anticancer agents comprising ∼1 500 published naturally occurring plant-based compounds from around the world. The results reveal that African medicinal plants could represent a good starting point for the discovery of anticancer drugs. The small data set generated (named AfroCancer) has been made available for research groups working on virtual screening.
- 25 August 2014
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 54 (9) , 2433-2450
Molecular Modeling of Potential Anticancer Agents from African Medicinal Plants
Naturally occurring anticancer compounds represent about half of the chemotherapeutic drugs which have been put in the market against cancer until date. Computer-based or in silico virtual screening methods are often used in lead/hit discovery protocols. In this study, the “drug-likeness” of ∼400 compounds from African medicinal plants that have shown in vitro and/or in vivo anticancer, cytotoxic, and antiproliferative activities has been explored. To verify potential binding to anticancer drug targets, the interactions between the compounds and 14 selected targets have been analyzed by in silico modeling. Docking and binding affinity calculations were carried out, in comparison with known anticancer agents comprising ∼1 500 published naturally occurring plant-based compounds from around the world. The results reveal that African medicinal plants could represent a good starting point for the discovery of anticancer drugs. The small data set generated (named AfroCancer) has been made available for research groups working on virtual screening.
- 5 August 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (75) , 40095-40110
The uniqueness and therapeutic value of natural products from West African medicinal plants, part III: least abundant compound classes
In this review, a continuation of our in-depth coverage of natural products derived from West African medicinal plants with diverse biological activities has been given.
- 5 August 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (75) , 40095-40110
The uniqueness and therapeutic value of natural products from West African medicinal plants, part III: least abundant compound classes
In this review, a continuation of our in-depth coverage of natural products derived from West African medicinal plants with diverse biological activities has been given.
- 1 August 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (67) , 35348-35370
The uniqueness and therapeutic value of natural products from West African medicinal plants, part II: terpenoids, geographical distribution and drug discovery
In this review series, an attempt has been made to give indepth coverage of natural products derived from West African medicinal plants with diverse biological activities.
- 1 August 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (67) , 35348-35370
The uniqueness and therapeutic value of natural products from West African medicinal plants, part II: terpenoids, geographical distribution and drug discovery
In this review series, an attempt has been made to give indepth coverage of natural products derived from West African medicinal plants with diverse biological activities.
- 15 May 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (54) , 28728-28755
The uniqueness and therapeutic value of natural products from West African medicinal plants. Part I: uniqueness and chemotaxonomy
This review gives an in depth coverage of the natural products derived from West African medicinal plants with diverse biological activities.
- 15 May 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (54) , 28728-28755
The uniqueness and therapeutic value of natural products from West African medicinal plants. Part I: uniqueness and chemotaxonomy
This review gives an in depth coverage of the natural products derived from West African medicinal plants with diverse biological activities.
- Open Access
- 6 March 2014
- Published by Springer Nature in Malaria Journal
- Vol. 13 (1) , 81
The potential of anti-malarial compounds derived from African medicinal plants, part II: a pharmacological evaluation of non-alkaloids and non-terpenoids
Malaria is currently a public health concern in many countries in the world due to various factors which are not yet under check. Drug discovery projects targeting malaria often resort to natural sources in the search for lead compounds. A survey of the literature has led to a summary of the major findings regarding plant-derived compounds from African flora, which have shown anti-malarial/antiplasmodial activities, tested by in vitro and in vivo assays. Considerations have been given to compounds with activities ranging from “very active” to “weakly active”, leading to >500 chemical structures, mainly alkaloids, terpenoids, flavonoids, coumarins, phenolics, polyacetylenes, xanthones, quinones, steroids and lignans. However, only the compounds that showed anti-malarial activity, from “very active” to “moderately active”, are discussed in this review.
- 6 March 2014
- Published by Springer Nature in Malaria Journal
- Vol. 13 (1) , 81
Open AccessThe potential of anti-malarial compounds derived from African medicinal plants, part II: a pharmacological evaluation of non-alkaloids and non-terpenoids
Malaria is currently a public health concern in many countries in the world due to various factors which are not yet under check. Drug discovery projects targeting malaria often resort to natural sources in the search for lead compounds. A survey of the literature has led to a summary of the major findings regarding plant-derived compounds from African flora, which have shown anti-malarial/antiplasmodial activities, tested by in vitro and in vivo assays. Considerations have been given to compounds with activities ranging from “very active” to “weakly active”, leading to >500 chemical structures, mainly alkaloids, terpenoids, flavonoids, coumarins, phenolics, polyacetylenes, xanthones, quinones, steroids and lignans. However, only the compounds that showed anti-malarial activity, from “very active” to “moderately active”, are discussed in this review.
- Open Access
- 5 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e90655
Virtualizing the p-ANAPL Library: A Step towards Drug Discovery from African Medicinal Plants
Natural products play a key role in drug discovery programs, both serving as drugs and as templates for the synthesis of drugs, even though the quantities and availabilities of samples for screening are often limitted. A current collection of physical samples of > 500 compound derived from African medicinal plants aimed at screening for drug discovery has been made by donations from several researchers from across the continent to be directly available for drug discovery programs. A virtual library of 3D structures of compounds has been generated and Lipinski’s “Rule of Five” has been used to evaluate likely oral availability of the samples. A majority of the compound samples are made of flavonoids and about two thirds (2/3) are compliant to the “Rule of Five”. The pharmacological profiles of thirty six (36) selected compounds in the collection have been discussed. The p-ANAPL library is the largest physical collection of natural products derived from African medicinal plants directly available for screening purposes. The virtual library is also available and could be employed in virtual screening campaigns.
- 5 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e90655
Open AccessVirtualizing the p-ANAPL Library: A Step towards Drug Discovery from African Medicinal Plants
Natural products play a key role in drug discovery programs, both serving as drugs and as templates for the synthesis of drugs, even though the quantities and availabilities of samples for screening are often limitted. A current collection of physical samples of > 500 compound derived from African medicinal plants aimed at screening for drug discovery has been made by donations from several researchers from across the continent to be directly available for drug discovery programs. A virtual library of 3D structures of compounds has been generated and Lipinski’s “Rule of Five” has been used to evaluate likely oral availability of the samples. A majority of the compound samples are made of flavonoids and about two thirds (2/3) are compliant to the “Rule of Five”. The pharmacological profiles of thirty six (36) selected compounds in the collection have been discussed. The p-ANAPL library is the largest physical collection of natural products derived from African medicinal plants directly available for screening purposes. The virtual library is also available and could be employed in virtual screening campaigns.